1-7 of 7
Michael McGuire
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Sequence of Lenalidomide (LEN) and Hypomethylating Agents (HMAs) and the Impact on Clinical Outcomes for Patients with Myelodysplastic Syndromes (MDS)

Amer M. Zeidan, MD, Andrew J Klink, PhD MPH, Bruce Feinberg, DO, Michael McGuire, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2188.
https://doi.org/10.1182/blood.V130.Suppl_1.2188.2188
Published: 2017
Journal Articles

Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R 2 ) in the US Medicare Population

Scott Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4706.
https://doi.org/10.1182/blood.V130.Suppl_1.4706.4706
Published: 2017
Journal Articles

Who Is Receiving Novel Therapies for Relapsed/Refractory Follicular Lymphoma? a Retrospective Chart Review of Recent Real-World Practice

James Signorovitch, PhD, Viviana Garcia-Horton, PhD, Marie Louise Ricculli, MS, Michael McGuire, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4707.
https://doi.org/10.1182/blood.V130.Suppl_1.4707.4707
Published: 2017
Journal Articles

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Scott F Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3574.
https://doi.org/10.1182/blood.V128.22.3574.3574
Published: 2016
Journal Articles

Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)

Aaron T. Gerds, MD MS, Shaloo Gupta, MS, Gary Binder, MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Stephanie Hawthorne, PhD, Kristen King-Concialdi, BS, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3541.
https://doi.org/10.1182/blood.V128.22.3541.3541
Published: 2016
Journal Articles

Early Treatment Initiation in Myelodysplastic Syndromes (MDS) Produces Higher Rate of and Earlier Transfusion Independence

Christopher R. Cogle, MD, Sheila R. Reddy, PhD RPh, Eunice Chang, PhD, Elya Papoyan, MPH, Michael S. Broder, MD MSHS, Michael McGuire, PharmD, Gary Binder, MBA
Journal: Blood
Blood (2016) 128 (22): 395.
https://doi.org/10.1182/blood.V128.22.395.395
Published: 2016
Journal Articles

Patterns of Treatment for Newly Diagnosed and Relapsed/Refractory Peripheral T-Cell Lymphoma in the Community Setting

Tatyana Feldman, MD, Michael McGuire, PharmD, Claudio Faria, PharmD, MPH, Andre Goy, MD, Charles M. Farber, MD PhD, Kelly Choi, MD, Jacqueline Connors, RN OCN, Dhakshila Paramanathan, Eric Schultz, Stuart L. Goldberg, MD
Journal: Blood
Blood (2015) 126 (23): 3952.
https://doi.org/10.1182/blood.V126.23.3952.3952
Published: 2015